|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.41 EUR | +0.75% |
|
+2.97% | -7.94% |
| 12:12am | ResMed tops quarterly profit estimates on strong demand for sleep apnea devices | RE |
| Apr. 23 | PHILIPS NV : Jefferies reiterates its Sell rating | ZD |
AMSTERDAM (Reuters) - Dutch health technology company Philips on Monday said it would scrap 6,000 jobs to restore its profitability following a recall of respiratory devices that knocked 70% off of its market value.
The new reorganisation comes on top of a plan announced in October to reduce its workforce by 5%, or 4,000 jobs, as it grapples with fallout from the recall of millions of ventilators used to treat sleep apnoea over worries that foam used in the machines could become toxic.
(Reporting by Bart Meijer; Editing by Tom Hogue)
| 1st Jan change | Capi. | |
|---|---|---|
| -7.94% | 18.71B | |
| +7.71% | 218B | |
| +6.25% | 182B | |
| +10.60% | 132B | |
| +26.73% | 108B | |
| -0.42% | 62.51B | |
| +15.42% | 52.98B | |
| -1.89% | 47.59B | |
| -1.91% | 39.96B | |
| +11.16% | 39.22B |
PHILIPS NV 
